Clinical Trial Update: Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of 5% minoxidil topical foam in women with androgenetic alopecia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• Minoxidil 5% topical foam (minoxidil)

Snippet

Sponsor: Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. | Conditions: Androgenetic Alopecia | Phase 3 | Status: RECRUITING